Pulmonary Fibrosis Awareness in general
Pulmonary Fibrosis (PF) is a progressive, irreversible, chronic lung disease causing scarring of the lung tissue with no known cure. In Europe it currently affects more than 300,000 people with over 50,000 losing their lives to PF each year. The most common type of PF is Idiopathic Pulmonary Fibrosis (IPF), accounting for 200,000 patients in Europe. The average life expectancy following diagnosis of PF or IPF is about three to five years, with a better prognosis depending on early diagnosis and adequate treatment.
EU-IPFF works in various ways to raise awareness of Pulmonary Fibrosis. We conduct awareness campaigns, develop material for carers, doctors and patients, arrange webinars and summits with professionals and specialists sharing their research, thoughts, knowledge and enthusiasm to really make a difference for people affected by PF.
Pulmonary Fibrosis Awareness Month 2021
Thanks for joining PF Awareness Month and IPF Awareness Week and helping raise awareness!